CA
NZ
UK
AU
IND
US
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) has made significant strides to enhance its communications withStakeholdersby providing an updated corporate presentation. This new presentation, dated August 13, 2026, offers insights into the company's proprietary Ultra Low Temperature Cryoablation technology among other topics. This initiative aims …
Addus HomeCare (NASDAQ: ADUS) appointed W. Bradley Bickham as interim chief operating officer, stepping in immediately after the departure of Heather Dixon. The change is intended to preserve continuity in the company’s day‑to‑day management, ensuring that ongoing initiatives remain on track. Because investors are …
Adial Pharmaceuticals (NASDAQ: ADIL) is poised to implement a series of leadership changes linked to its imminent annual meeting vote. The planned transition underscores the company’s commitment to refining its governance practices, potentially impacting decision-making processes and strategic direction. By initiating these changes, Adial …
Mdxhealth's financial results for the second quarter show significant growth amid challenges. The company reported revenue of $27.2 million, a 16% increase from the prior year’s $23.4 million. This growth was driven by a successful transition of its commercial operations and the increasing test …
Akari Therapeutics (NASDAQ: AKTX) disclosed that its experimental PH1 payload achieved a preclinical synergy when combined with a KRAS inhibitor in pancreatic disease models, broadening the company’s oncology credentials. This synergistic effect reflects a functional interaction that appears to amplify tumor cell killing beyond …
AbCelleraBiologicshas entered a new material agreement that widens access to its antibody discovery platform, offering investors upside through broader collaboration possibilities. The deal enhances the company’s capacity to partner with pharmaceutical firms and accelerate pipeline development.
Lexaria Bioscience (NASDAQ:LEXX) shares are pulling back modestly in pre-market trading, giving back a small piece of Thursday's sharp 32.35% rally that followed the announcement of a new partnership. The Kelowna, Canada-based company is a drug delivery innovator known for its patented DehydraTECH technology, …
MapLight Therapeutics (NASDAQ:MPLT) shares are climbing in pre-market trading after the clinical-stage biopharmaceutical company reported positive Phase 2 results and provided aBusinessupdate alongside its second-quarter earnings. MapLight is a Redwood City, California-based company focused on developing circuit-specific therapies for central nervous system disorders including …
Valneva SE (NASDAQ:VALN) shares are surging in pre-market trading after theEuropean Medicines Agency (EMA)validated the Marketing Authorization Application (MAA) for PF-07307405, the company's 6-valent outer surface protein A (OspA)-based Lyme disease vaccine candidate developed inPartnershipwith Pfizer. Validation means the EMA has accepted the application …
Zentalis Pharmaceuticals (NASDAQ:ZNTL) shares are trading lower in pre-market trading after the clinical-stage oncology company announced the pricing of a dilutive share offering. The San Diego-based company is a clinical oncology innovator advancing late-stage development of azenosertib, an investigational, potentially first-in-class WEE1 inhibitor being …
Please wait processing your request...